Scientist.com has announced a partnership with 5AM Ventures, a venture capital firm focused on building next-generation life science companies. Over 70 companies associated with 5AM can now use a 5AM-branded R&D marketplace that simplifies research outsourcing, saves time and money, and provides access to the latest innovative research tools and technologies.
“The 4:59 Initiative is the internal company creation effort within 5AM that conceives, builds, and funds breakthrough science and establishes early, proof-of-principle data that enables Series A financing,” said Andy Schwab, 5AM Managing Partner. “By providing rapid and cost-effective access to services and experts, the 5AM R&D marketplace allows our seed and early-stage companies to compete head-to-head with pharma companies that are a thousand times their size.”
Start-up companies are increasingly pursuing a virtual approach to medical research in which most R&D is outsourced to external CROs. R&D marketplaces like Scientist.com make it easy for start-up company researchers to connect with experts, design experiments and then purchase outsourced R&D services on demand.
“Through the R&D marketplace created with Scientist.com, the 5AM portfolio can engage with pre-clinical and clinical research services and connect with hundreds of industry-leading experts,” said Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “A small experienced team of drug hunters or even a single person can now run research projects that ten years ago would have required the concerted effort of hundreds of pharmaceutical researchers.”